Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|March 7, 2003
Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patientsHarumi Takahashi, Grant R Wilkinson, Yoseph Caraco, et al.Investigative Ophthalmology & Visual Science|January 26, 2007
Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2Masahiko Shibuya, Haru Okamoto, Takehiro Nozawa, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 28, 2003
Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptomsKeiko Ohno, Shinsuke Miyazawa, Masayuki Hashiguchi, et al.Clinical Medicine Insights. Oncology|November 10, 2017
Consequences of Different Corticosteroids on Serum Potassium and Prostate-Specific Antigen in Patients Receiving Abiraterone for Castration-Resistant Prostate Cancer: A Retrospective Observational StudyMasaomi Tatsuzawa, Ryuichi Ogawa, Naoki Kinjo, et al.Clinical Pharmacokinetics|September 29, 2012
Inter-individual differences in baseline coagulation activities and their implications for international normalized ratio control during warfarin initiation therapyYosuke Ichimura, Harumi Takahashi, Michael T M Lee, et al.European Journal of Clinical Pharmacology|November 19, 2020
Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgeryMizuho Asada, Masashi Nagata, Tomohiro Mizuno, et al.Pharmacology Research & Perspectives|November 10, 2018
Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgeryMizuho Asada, Masashi Nagata, Tomohiro Mizuno, et al.Journal of Clinical Pharmacology|January 7, 2006
Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmiasRyuichi Ogawa, Ryoji Kishi, Kiyoshi Mihara, et al.Therapeutic Drug Monitoring|January 7, 2009
Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?Hirokazu Nakayama, Hirotoshi Echizen, Tomoko Gomi, et al.Pharmacogenomics|December 21, 2016
Correlations between the enantio- and regio-selective metabolisms of warfarinHarumi Takahashi, Minami Ohara, Soichi Shibata, et al.Pageof 6